background: Comparative genomic hybridization (CGH) is a valuable alternative to fluorescence in situ hybridization (FISH) for preimplantation genetic screening (PGS) because it allows full karyotype analysis. However, this approach requires the cryopreservation of biopsied embryos until results are available. The aim of this study is to reduce the hybridization period of CGH, in order to make this short-CGH technique suitable for PGS of Day-3 embryos, avoiding the cryopreservation step.
Introduction
Preimplantation genetic screening (PGS) is currently applied to evaluate the presence of aneuploidies in embryos of couples at risk of chromosome abnormalities, i.e. advanced maternal age (AMA), recurrent miscarriage (RM), recurrent IVF failure or severe male factor (Donoso et al., 2007) . Nevertheless, the implantation rate after this procedure is about 14.3% (2433 positive heart beat/16 975 embryos transferred), according to the European Society of Human Reproduction and Embryology PGD Consortium data collection I -IX (Goossens et al., 2009) . The technique routinely used for PGS is fluorescence in situ hybridization (FISH), which is a fast and easy method to perform. However, some studies have recently questioned the validity of PGS using FISH, as it has been observed that this analysis not only does not increase the implantation and delivery rate in women under the age of 36 years (Staessen et al., 2008) , but also causes a decrease in the clinical pregnancy rate in women of AMA (Hardarson et al., 2008) .
Although mosaicism has been reported to exist in preimplantational embryos, affecting the accuracy of PGS (Munne et al., 1994; Bielanska et al., 2002; Li et al., 2005) , another reason why the implantation rate is not improved by PGS using FISH is probably the fact that the whole set of chromosomes is not analysed and aneuploidies in chromosomes that are not screened could be hampering the implantation or development of transferred embryos. Comparative genomic hybridization (CGH) is a well-established procedure which allows for the study of all chromosomes simultaneously. It was first developed to examine genomic DNA from tumours (Kallioniemi et al., 1992) , and subsequently the protocol was adapted to the study of DNA from single cells (Voullaire et al., 1999; Wells et al., 1999) . The main advantage of CGH over FISH is that the whole chromosomal complement can be ascertained and this also allows for the detection of not only chromosomal imbalances generated by aberrant segregation but also structural imbalances of fragments larger than 10 -20 Mb (Griffin et al., 1998; Malmgren et al., 2002) . However, CGH is a rather labourintensive technique and it takes 4 days to obtain results. For this reason, two strategies have been developed to enable its application in PGD. The first strategy is the use of the first polar body (1PB) (Wells et al., 2002; Sher et al., 2007; Obradors et al., 2008 Obradors et al., , 2009 or the first and second polar bodies (1PB and 2PB) as indirect indicators of the oocyte's chromosomal complement, in which case, only maternal contribution of first or first and second meiotic division, respectively, is determined and paternal meiotic and post-zygotic errors cannot be detected. In order to obtain a more complete analysis, a second strategy has been developed, based on the CGH analysis of one blastomere from Day-3 embryos (Wilton et al., 2001; Voullaire et al., 2002; Sher et al., 2009) or of several cells removed from the trophectoderm at the blastocyst stage Schoolcraft et al., 2009) . Nevertheless, owing to the duration of CGH, these two approaches require the cryopreservation of the biopsied embryos and the transfer of those diagnosed as euploid in a subsequent cycle.
It is well known that slow cryopreservation method produces a decrease in the survival rate of frozen and thawed embryos after PGS (Joris et al., 1999; Zheng et al., 2005) . Moreover, this procedure leads to a 30 -40% reduction in implantation potential (Joris et al., 1999; Edgar et al., 2000) . Recently, the development of the vitrification procedure has improved the survival rate of thawed embryos (Mukaida et al., 2003) , especially at the blastocyst stage (Zhang et al., 2009) . Nevertheless, the most propitious situation for embryos, patients and the IVF laboratory would be to avoid the cryopreservation step altogether and to transfer fresh embryos selected after the application of a comprehensive analysis of all chromosomes, compatible with the timing of the IVF cycle.
Lately, array-CGH technology has emerged, allowing a faster, more comprehensive analysis of PBs and preimplantation embryos (Hu et al., 2004; Wells et al., 2004; Le Caignec et al., 2006) . However, this procedure needs to be completely validated and, to date, its cost is far higher than the conventional CGH.
The aim of this work is to develop and validate a CGH variant conserving all advantages of the conventional CGH, including its cost, but avoiding the cryopreservation of the embryos. For this purpose, a considerable reduction in the time required for the protocol is needed. Lately, an approach to this objective has been designed, achieving a faster CGH protocol that allows for the aneuploidy screening of the whole chromosomal complement in 16 h using indirect labelling (Landwehr et al., 2008) . In the present work, a different approach has been taken, introducing some modifications in the earlier procedure developed by our group (Gutierrez-Mateo et al., 2004a) , making the CGH methodology suitable for PGS of Day-3 embryos, without the need of cryopreservation. Forty-eight blastomeres from 10 Day-4 embryos, discarded after PGS by FISH with nine probes (13, 15, 16, 17, 18, 21, 22, X, Y) , were used in this study. The embryos were donated by six women with normal karyotype. The age range of patients was between 34 and 50 years, with an average age of 41 years. They were candidates for PGS because of the following indications: RM (n ¼ 1), male factor with abnormal FISH (n ¼ 1), RM + male factor with abnormal FISH (n ¼ 1), AMA (n ¼ 2) and male factor with abnormal FISH + AMA (n ¼ 1). Embryos were obtained from the IVF laboratories of the Clínica Sagrada Família, Institut Valencià d'Infertilitat and Institut Marquès, Barcelona, Spain. The signature of corresponding Informed Consent was obtained from all families involved in the study and the work was approved by the respective Ethics Committees.
Materials and Methods

Fibroblast and blastomere recovery
Isolation and lysis of fibroblasts and blastomeres
A drop of a highly diluted cell suspension from a confluent culture was placed on a small plate under a stereoscopic microscope and a single fibroblast was isolated using a 170-mm denuding pipette (Cook Ireland Ltd). The fibroblast was washed in four phosphate-buffered saline (PBS)/0.1% polyvinyl alcohol (PVA) droplets and transferred to a PCR tube.
For the embryos, the zona pellucida was removed using Tyrode's acid or pronase (3 mg/ml) and blastomeres were isolated, washed and stored in the same way as fibroblasts. A minimum of two blastomeres were obtained from eight of the embryos and a single blastomere was obtained from two of the embryos.
Every PCR tube containing either one fibroblast or one blastomere was properly coded with a different number from the original, so that the CGH analysis was conducted blindly.
Although single fibroblasts from a female were used as reference in the fibroblast lines analyses, single lymphocytes from a male were used in the blastomeres experiments. Both fibroblasts and lymphocytes were obtained from confluent cultures and stored individually in PCR tubes.
Lysis of fibroblasts, blastomeres or lymphocytes were performed adding 1 ml of sodium dodecyl sulphate (17 mM) and 2 ml of proteinase K (125 mg/ml) to each sample, this was overlaid with light mineral oil, and the tubes were incubated at 378C for 1 h, followed by 10 min at 958C to inactivate proteinase K.
Short comparative genomic hybridization
Whole genome amplification Single cell DNA was amplified using degenerate oligonucleotide primed PCR (DOP-PCR) as previously described (Gutierrez-Mateo et al., 2004a) but in this case a shortened reaction, with fewer PCR cycles, was tested to reduce the processing time from 5 to 3 h 40 min: the sample was heated to 958C for 5 min; 10 cycles of 958C for 1 min, 308C for 1.5 min and 688C for 3 min; 20 cycles of 958C for 1 min, 628C for 1 min and 688C for 2.5 min with a final extension step of 688C for 7 min. The PCR programme was carried out in a Tgradient thermocycler (Biometra, Goettingen, Germany) and electrophoresis on a 1.5% agarose gel was used to evaluate the correct DNA amplification (smear between 200 and 4000 bp) of each sample.
Labelling and precipitation of probes
Whole genome amplification products were fluorescently labelled by nick translation (Abbott) according to the manufacturer's instructions, with a step of 158C for 1 h 30 min and another step of 708C for 10 min. Test DNA (fibroblasts or blastomeres) was labelled with Spectrum Red-dUTP (Abbott), whereas reference DNA (fibroblasts or lymphocytes) was labelled with Spectrum Green-dUTP (Abbott). In order to obtain a homogeneous control DNA probe, different reference DNAs were mixed after their individual labelling.
After nick translation, reference and test DNA were mixed in equimolar proportions and ethanol precipitated with 10 mg of Cot-1-DNA (Abbott). The precipitation process took 1 h at 2808C and 30 min of centrifugation. The pellet was dried and dissolved in 8 ml of hybridization mixture (50% formamide, 2× standard saline citrate, 10% dextran sulphate, pH 7).
Comparative genomic hybridization
Hybridization was performed on normal male (46,XY) metaphase spreads (Abbott) with some modifications of a previous method (Gutierrez-Mateo et al., 2004a) , including a microwave step and agitation of the slides during hybridization. Immediately after a 30-min exposure in a 75 W microwave (Optiquick Compact, Moulinex) in humid conditions, a reduction in the hybridization step, from 72 to 12 h, was achieved when the slides were kept in a moist chamber at 378C with rotary agitation (65 rpm/min) for the whole incubation period, using a 1309-1CE rotator (Lab-line Instruments Inc.; USA).
Image capture and CGH analysis
The capture of metaphases was performed with a Nikon eclipse 90i epifluorescence microscope. An average of 12 metaphases per cell was captured and evaluated using Isis CGH software developed by MetaSystems. The ratio between red and green fluorescence is 1:1 when there is the same proportion of reference and test DNA. The thresholds used to diagnose losses and gains were 0.8 and 1.2, respectively. Deviations of the ratio within the threshold cut-off of 0.8 or 1.2 were also taken into account to evaluate the sensitivity of the technique.
Criterion of CGH analysis
It is important to mention that chromosomes that are potentially gained or lost artifactually, i.e. chromosomes 17, 19 and 22 (Moore et al., 1997; Voullaire et al., 2002; Gutierrez-Mateo et al., 2004a) were excluded from analysis when all three chromosomes were simultaneously gained or lost in the same cell; otherwise they were considered as being real aneuploidies.
In the present work no distinction between chromosome or chromatid gain or loss has been considered because, in our experience analysing 1PBs and their corresponding metaphase II (MII) using CGH and FISH, respectively, the CGH loss or gain profiles of the 1PBs were indistinguishably equivalent to losses or gains of either chromosome or chromatid in the MIIs (Gutierrez-Mateo et al., 2004b) .
Validation of 12-h hybridization results
After whole genome amplification of single cell DNA, the product can be divided and labelled, obtaining two sets of nick translation products. We used one set to perform the 12 h hybridization and the other to validate the short-CGH results using the standard, 72 h-CGH.
Clinical application
The short-CGH was applied in a clinical case. A couple at risk of aneuploidy in the offspring owing to AMA (41 years old) was included in an IVF programme in collaboration with the Fundació Puigvert-Hospital de Sant Pau in Barcelona to perform the PGS. The patient underwent a routine ovulation induction procedure and eight mature oocytes were retrieved on Day 0. Seven out of the eight oocytes showed two pronuclei on Day + 1 after ICSI, indicating that they had been fertilized. Early in the morning of Day + 3, one blastomere was biopsied from each of the six embryos that reached the 6 -8 cell stage in order to perform the short-CGH. Each blastomere was washed in PBS/0.1% PVA solution and was put into a labelled 0.2 ml PCR tube and kept at 2208C. The short-CGH protocol was applied. The process started on Day + 3, taking 1 h 10 min for the cellular lysis, 5 h for DOP-PCR, 1 h 40 min for nick translation, 1 h 30 min for DNA precipitation and 1 h for slide preparation. Sample manipulation at each step added 1 h to the global handling duration. Therefore, the whole protocol lasted 11 h 20 min before the 12 h incubation period (during the night). The capture of metaphases and the CGH analysis were performed during the morning of Day + 4.
Results
Modifications in the standard CGH protocol
In isolated fibroblasts, the application of the shortened whole genome amplification procedure (3 h 40 min DOP-PCR) yielded an amount of DNA product similar to that obtained with the standard one (5 h DOP-PCR). Only 2 out of 32 fibroblasts failed to give any smear in the 1.5% agarose gel, so the amplification efficiency was 93.75%.
High-quality, homogeneous hybridizations were obtained when the short-CGH variant (12 h of hybridization) was applied to isolated fibroblasts using DNA probes obtained after 3 h 40 min DOP-PCR. Consequently, that led to reliable CGH profiles with very few deviations, showing the high sensitivity of the modified technique, which was similar to the one obtained using the standard, 72 h-CGH (Fig. 1) .
The short-CGH allowed the detection of all the characteristic aneuploidies in each cell line in 100% of the single fibroblasts (n ¼ 30) analysed. No other aneuploidies or imbalances were observed ( Fig. 1 ; Table I ).
After developing the short procedure for single fibroblasts it was tested for isolated blastomeres. All the methodological modifications were also validated in single blastomeres, except for the shortened whole genome amplification. The 3 h 40 min DOP-PCR was not as successful as in fibroblasts; for this reason, the 5 h DOP-PCR was kept for isolated blastomeres, as in the standard CGH procedure.
Agreement between short-CGH and FISH
The short-CGH procedure was applied in a total of 48 isolated blastomeres from 10 embryos, which were discarded after PGS by FISH with nine chromosome probes 15, 16, 17, 18, 21, 22, X and Y) . Results are shown in Table II .
In all 48 blastomeres the standard 72 h-CGH and short-CGH gave the same results, so total agreement was found between the two approaches (Fig. 2) .
According to the concordance between short-CGH and 9-chr-FISH results, blastomeres were classified in three categories: (i) 20 out of 48 blastomeres (41.6%) showed total agreement, as all aneuploidies found by FISH were confirmed by short-CGH (i.e. blastomeres 1.1, 4.1); (ii) 11 blastomeres (22.9%) showed partial agreement, as some abnormalities were concordant but there were other aneuploidies either not detected by FISH or not detected by short-CGH (i.e. blastomeres 1.7, 2.4) and (iii) 17 blastomeres (35.4%) showed discordant results between the two techniques (i.e. blastomeres 7.1, 8.1).
Reanalysis of blastomeres which had discordant results was performed by re-hybridization with telomeric FISH probes for particular chromosomes involved in the disagreement (blastomeres 5.0, 6.0, 7.0, 8.0 and 9.0), and the results were in total agreement with short-CGH results.
Aneuploidy detection by short-CGH
Although the first interpretation of FISH results had led to the conclusion that all discarded embryos were aneuploid, at least for the analysed blastomere (except for embryo 4, which was rejected for having stopped its development), out of the 48 blastomeres evaluated by short-CGH, 14 blastomeres (29.2%) belonging to three embryos did not present any aneuploidy and 34 blastomeres (70.8%) were aneuploid (Table II; Fig. 3 ). The chromosomes most frequently involved in aneuploidy were 22 and 16, but also aneuploidies for chromosomes 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15, 17, 18, 19, 20, 21 , X and Y were detected. Overall, we found 94 aneuploid events, 41 (43.6%) of them corresponding to chromosomes which are not analysed by 9-chr-FISH.
Mosaicism was found in five of the eight embryos that had more than one blastomere analysed (embryos 1, 2, 3, 5 and 9). Complementary aneuploidy events between two blastomeres of the same embryo were observed (blastomeres 1.5 and 1.6, blastomeres 3.1 and 3.2 and blastomeres 9.2 and 9.10). Moreover, the comprehensive analysis of embryo three showed a chaotic segregation (Table II) .
Results of the first short-CGH clinical application
Five out of the six blastomeres obtained after Day-3 embryo biopsy produced optimal DOP-PCR products, showing a smear in the agarose gel between 200 and 4000 bp, with three extra bands of 1650, 1250 and 600 bp, corresponding to mitochondrial DNA amplification. The analysis of the short-CGHs showed aneuploidies in all five blastomeres, involving one to three chromosomes, particularly chromosome 18, which was aneuploid in three out of the five embryos (Table III; Fig. 4) . Embryo 4, which produced suboptimal amplification product and, consequently, was not diagnosed, was not transferred owing to its poor developmental potential, according to the morphology criteria. Therefore, no embryo transfer was performed in this clinical case.
Discussion
Time-reduction of CGH protocol using fibroblasts
According to the results obtained in the present work, a short-CGH single cell analysis has been successfully developed. Some modifications in the procedure used by our group (Gutierrez-Mateo et al., 2004a) , which had its basis in the previously published protocol (Wells et al., 1999) , allowed us to develop a reliable, faster CGH protocol. With a 100% success rate using the short-CGH procedure, all specific aneuploidies of the analysed fibroblasts, and exclusively them, were identified. In our hands, single fibroblast DNA amplification product obtained when DOP-PCR was shortened to 3 h 40 min was similar to that obtained by the standard 5 h DOP-PCR protocol. Nonetheless, the key to success of the short protocol was the fact that the slides were kept in rotary agitation inside the humid chamber for the entire 12 h incubation, after having treated them in the microwave at 75 W for 30 min. Probably, rotary movement permits a better diffusion of probe molecules through complementary sequences of the denatured chromatin of lymphocyte metaphases in the slide, allowing for faster and more uniform hybridization. In fact, the introduction of agitation during the hybridization period had been previously published, also reducing the CGH procedure to 16 h and achieving very promising results (Landwehr et al., 2008) . Moreover, the microwave treatment used in the hybridization step has been widely applied in different cell samples, getting very good results in faster FISH and increasing the sensitivity and specificity of signals (Multani et al., 1996; Determination of male gender in isolated fibroblasts from male cell lines was considered as an indicator of in situ hybridization quality. That is, 12 metaphases per case were captured and 24 chromosomes were analysed for each autosome, whereas only half of them were available for chromosomes X and Y. Thus, using fibroblast DNA from a female as reference, the loss of chromosome X and the gain of chromosome Y were detected analysing only 12 chromosomes for each sex chromosome. Therefore, it meant CGH was performed successfully and high-quality was achieved.
Similar, or in some cases better, hybridizations and better-defined CGH profiles were observed when the same CGH-DNA probe, obtained after 3 h 40 min DOP-PCR, was used in the short protocol (12 h of hybridization) versus the standard protocol (72 h of hybridization). It is possible that reduction of the hybridization period avoids non-specific unions, resulting in less background detected by the CGH software analysis. Combining this with the fact that microwave treatment and rotary movement improve process efficiency, short-CGH is consolidated as a reliable and faster procedure for aneuploidy analysis in fibroblasts.
Adaptation of short-CGH protocol to single blastomeres
Practically the same short-CGH procedure was appropriate for aneuploidy analysis of isolated blastomeres, except for the shortened whole genome amplification, as lower DNA amplification was detected in blastomeres versus fibroblasts when 3 h 40 min DOP-PCR was applied. Thus, according to the results, the short-CGH for blastomeres was improved using the 5 h DOP-PCR procedure. In this way, very good hybridization and highly discriminative CGH profiles were obtained. Even in blastomeres, the quality of results obtained with the short-CGH procedure was similar, or in some cases better, than that obtained with the standard CGH protocol (72 h of hybridization). Therefore, these results were as reliable for use in aneuploidy screening as the 72 h-CGH and 40 h-CGH results previously obtained by our group (Gutierrez-Mateo et al., 2004a; Obradors et al., 2008 Obradors et al., , 2009 ).
Reliability of short-CGH analysis
In 41.6% (20/48 blastomeres) of the analysed blastomeres concordance was found when comparing short-CGH results with 9-chr-FISH. However, in six of them, the CGH procedure allowed for the detection of aneuploidies in chromosomes which were not analysed by FISH. Partial agreement was found in 22.9% (11/48) of the studied blastomeres, since either not all of the aneuploidies diagnosed by 9-chr-FISH were corroborated by short-CGH, or aneuploidies that could have been detected by 9-chr-FISH were observed in the CGH analysis. Finally, discordance between short-CGH and 9-chr-FISH was observed in 35.4% (17/48) of the blastomeres, as none of the diagnosed aneuploidies were corroborated by short-CGH. At that point, apart from a possible CGH error, originating from overamplification of some single cell genomic regions (which Short comparative genomic hybridization in fact were not observed when aneuploid fibroblasts were previously analysed), the following two considerations about those contradictory results could be discussed: mosaicism and/or FISH error. Mosaicism is a phenomenon that has been observed extensively in this work, as five of the eight embryos that had more than one blastomere analysed were mosaic, and it has been widely reported, affecting about 30% of the cleavage-stage embryos (Munne et al., 1994) . On the other hand, the re-hybridization of discordant blastomeres with telomeric FISH probes revealed that discordance between the short-CGH and 9-chr-FISH results originated from FISH errors (Table II) . In fact, it has been described that intrinsic FISH factors, such as chromosome overlapping or loss of micronuclei during fixation, may account for the diagnosis of false monosomies (Munne et al., 1996; Bahce et al., 2000) (i.e. blastomeres 5.0, 6.0 and 8.0) . Otherwise, false trisomies (i.e. blastomeres 7.0 and 9.0) might be diagnosed as a result of split signals caused by the overlapping of similar fluorochromes (Munne et al., 1998) . The mentioned FISH errors produced an incorrect diagnosis that led to the discarding of embryos 7 and 8 for being aneuploid while, subsequently, by short-CGH they were diagnosed as being euploid. For this reason, it is important to consider the value of short-CGH versus FISH and the need for caution in the diagnosis. According to our results, if PGS of embryos included in this study had been performed using short-CGH, the diagnosis may have been more accurate. In fact, it has been described that FISH has partial screening potential, since analysing, in the best cases, 12 of the 23 total chromosome pairs, aneuploidies affecting the rest of the chromosomes remain undetected in .40% of cases (Bielanska et al., 2002) . This is in agreement with results obtained in this study, as overall we found 94 aneuploid events, 41 (43.6%) of them corresponding to chromosomes which were not analysed by 9-chr-FISH.
Thus, the main source of error in a diagnosis by short-CGH would be embryo mosaicism, but contrary to what has been stated (Staessen et al., 2008) , it does not imply that PGS success using CGH is similar to that using FISH. Although it is true that by analysing more chromosomes it is possible to detect more aneuploidies that do not necessarily exist in the rest of the embryo, this is not a reason to reject a comprehensive and highly reliable analysis such as CGH. To date, the low implantation rate described after PGS (Mastenbroek et al., 2007; Hardarson et al., 2008; Staessen et al., 2008) has been observed in studies that used FISH as the screening method. Conversely, when PGS has been applied to the whole chromosome complement, even in couples with little chance of success, the implantation rate of transferred embryos has increased (Hellani et al., 2008) . More extensive series of PGS, analysing the full karyotype in isolated blastomeres, are needed before this short-CGH approach is rejected or supported. But this is independent of the fact that mosaicism is one of the major causes of diagnostic errors and that it will never be entirely eliminated. In this way, this study is a preliminary validation of short-CGH results by 72 h-CGH and FISH reanalysis, which presents the short-CGH approach as a reliable technique to be applied in the aneuploidy analysis of blastomeres.
Having a comprehensive diagnosis and avoiding cryopreservation
To date, the only way to perform CGH in a PGD avoiding cryopreservation of biopsied embryos is by analysing the 1PB of oocytes (Wells et al., 2002; Sher et al., 2007; Obradors et al., 2008 Obradors et al., , 2009 Obradors et al., , 2010 . But, in this case, only maternal complement resulting from meiosis I is examined, whereas second meiotic division, paternal and post-zygotic aneuploidy remains undetected.
With all of the changes we introduced in the standard CGH protocol, it is now possible to apply this modified, short-CGH technique to comprehensive PGS of Day-3 blastomeres without cryopreserving the analysed embryos. On Day+3, the blastomere biopsy is carried out early in the morning and cell lysis, amplification by DOP-PCR, labelling by nick translation, DNA precipitation and slides preparation are carried out within 11 h 20 min on the same day. Hybridization takes place in 12 h during the night and results are obtained on Day+4 in the morning. Although the duration of the whole protocol depends on the number of samples processed, having an adequate team of specialized technicians, PGS using short-CGH is completely applicable. In our hands, short-CGH analysis takes 30 min per cell using two intranet-connected systems of analysis, allowing for the embryo transfer on the same Day+4 in the afternoon or on Day+5, depending on the number of embryos to be analysed. Performing the transfer of embryos that have not been cryopreserved during the analysis could mean an increase of implantation rate and embryo survival. Actually, in a PGS requiring cryopreservation, after discarding one part of the embryos for being aneuploid and losing another part which does not survive the freezing and thawing process, the number of euploid embryos with the correct development that can be transferred is extremely reduced. Lately, the vitrification methodology has shown an increase of success after CGH-PGS Sher et al., 2009) . However, the most propitious situation would be to avoid the cryopreservation step: first, this would help to reduce embryo manipulation, second, it would prevent patients from having medical treatment in a subsequent cycle and third, the routine application of the short-CGH procedure would allow embryologists to remove the handicap of cryopreservation from the PGS cycle.
Recently, microarray technology has been focused on cytogenetic analysis, developing a more simplified and rapid method which allows for an automated analysis of results. Mainly, there are two approaches for this purpose: single nucleotide polymorphism array (SNP-array) and CGH-array. The SNP-array is based on the analysis of common polymorphic DNA sequences found throughout the genome, and it enables the detection of chromosome imbalance and genome wide linkage analysis (Handyside et al., 2009; Vanneste et al., 2009) . The second one, CGH-array, has its basis in the standard CGH but, in this case, the test and reference DNA are hybridized to DNA probes fixed to a slide rather than metaphase chromosomes. Encouraging results using CGH-arrays have been obtained by several groups (Hu et al., 2004; Wells et al., 2004; Le Caignec et al., 2006) and even two clinical applications have been successfully performed (Hellani et al., 2008; Fishel et al., 2009) . However, although CGH-array is being extensively validated, further research is needed to improve its ability to distinguish between real and artifactual gains and losses in arrays with oligonucleotide probes, to overcome the lack of resolution of CGH-array using chromosome libraries or to solve the lack of accuracy of bacterial artificial chromosome-arrays . Furthermore, to date, another essential limitation of CGH-array technology is the cost of the equipment required, which greatly exceeds that of standard CGH. Thus, our new short-CGH protocol seems to be one of the most appropriate techniques to use in PGS until the optimal combination of accuracy, speed and cost of array-CGH is established and widely applied.
In this work, short-CGH has been successfully applied in one clinical case, providing an accurate diagnosis of the analysed blastomeres. Although embryo transfer was not possible because of aneuplodies in all the screened embryos, this first application demonstrates the feasibility of using short-CGH in clinical PGS.
In conclusion, our preliminary results suggest that short-CGH is a reliable procedure for use in a comprehensive PGS of single blastomeres. This approach could also be applicable to PBs or blastocyst analysis, being faster than conventional CGH (and avoiding cryopreservation in PB analysis) and cheaper than CGH-arrays. The short-CGH technique is a valuable alternative to FISH for predetermined chromosomes because it provides a complete aneuploidy screening of all chromosomes. In addition, if applied in Day-3 blastomeres, short-CGH results are obtained on Day+4, avoiding the cryopreservation of biopsied embryos.
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